| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Dana Wy Tsui | |
| Rossa Wk Chiu | |||
| Ym Dennis Lo | |||
| P2860 | cites work | Detection of fetal RHD-specific sequences in maternal plasma | Q77429872 |
| Fetal cells in maternal blood as a second non-invasive step for fetal Down syndrome screening | Q77482462 | ||
| Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation | Q77678904 | ||
| Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients | Q77804773 | ||
| Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia | Q77945374 | ||
| Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study | Q78014625 | ||
| Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction | Q78175404 | ||
| Feto-maternal microchimerism in connective tissue diseases | Q78516511 | ||
| Cancer epigenetics | Q81611376 | ||
| Genome-wide profiling of promoter methylation in human | Q82241025 | ||
| Amniocentesis and chorionic villus sampling for prenatal diagnosis | Q24247990 | ||
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 | ||
| Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 | ||
| A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands | Q24562877 | ||
| Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 | ||
| High sensitivity mapping of methylated cytosines | Q24630600 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis | Q24651226 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Comparative isoschizomer profiling of cytosine methylation: the HELP assay | Q24685607 | ||
| Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma | Q28138323 | ||
| Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum | Q28207159 | ||
| The epigenomics of cancer | Q28289975 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| DNA methylation landscapes: provocative insights from epigenomics | Q29617144 | ||
| Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells | Q29618090 | ||
| Role for DNA methylation in genomic imprinting | Q29618669 | ||
| Model-based analysis of tiling-arrays for ChIP-chip. | Q30821016 | ||
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Hypermethylation of RASSF1A in human and rhesus placentas | Q33275493 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease | Q33489738 | ||
| Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing | Q33534062 | ||
| Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome | Q33595266 | ||
| Epigenetics in the placenta | Q33620204 | ||
| Microchimerism: implications for autoimmune disease | Q33716530 | ||
| DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta | Q33744584 | ||
| Methylated DNA immunoprecipitation and microarray-based analysis: detection of DNA methylation in breast cancer cell lines | Q33754737 | ||
| Sensitive digital quantification of DNA methylation in clinical samples | Q33761814 | ||
| Microchimerism of maternal origin persists into adult life. | Q33853463 | ||
| Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism | Q34032332 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Fetal DNA in maternal plasma: biology and diagnostic applications | Q34098822 | ||
| Role of paternal and maternal genomes in mouse development | Q34261845 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins | Q34385179 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| The emerging science of epigenomics | Q34566933 | ||
| Next-generation sequencing transforms today's biology | Q34731728 | ||
| DNA methylation in cancer: too much, but also too little | Q34770545 | ||
| Effect of site-specific modification on restriction endonucleases and DNA modification methyltransferases | Q34871498 | ||
| Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. | Q34902566 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| Clinical practice. Prenatal screening for aneuploidy | Q34986134 | ||
| Microchimerism in autoimmune disease: more questions than answers? | Q35171973 | ||
| PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies | Q35249607 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. | Q36915075 | ||
| MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. | Q36986986 | ||
| Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma | Q37000915 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies | Q37164146 | ||
| Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface | Q37200849 | ||
| Non-invasive prenatal diagnosis by single molecule counting technologies | Q37525261 | ||
| Methyl-specific DNA binding by McrBC, a modification-dependent restriction enzyme | Q38312742 | ||
| DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight | Q39853397 | ||
| Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. | Q39904859 | ||
| Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. | Q39949853 | ||
| Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
| Prenatal diagnosis by analysis of fetal cells in maternal blood | Q40923888 | ||
| Comprehensive high-throughput arrays for relative methylation (CHARM). | Q42155651 | ||
| Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism | Q43073795 | ||
| Two-way cell traffic between mother and fetus: biologic and clinical implications. | Q44133343 | ||
| Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study | Q44552941 | ||
| Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood | Q46167117 | ||
| Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma | Q47391690 | ||
| Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. | Q47889241 | ||
| Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report | Q48004844 | ||
| Tissue-specific differences in DNA methylation in various mammals | Q48793834 | ||
| Maternal plasma fetal DNA as a marker for preterm labour. | Q50851221 | ||
| Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. | Q53063252 | ||
| Increased cell-free fetal DNA in plasma of two women with invasive placenta. | Q54277406 | ||
| Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. | Q54574187 | ||
| Profiling DNA methylation patterns using genomic tiling microarrays. | Q54643204 | ||
| High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. | Q54648888 | ||
| Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. | Q54753744 | ||
| Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome | Q56765605 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients | Q57240090 | ||
| Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21 | Q58029321 | ||
| Quantitative aberrations of hypermethylatedRASSF1A gene sequences in maternal plasma in pre-eclampsia | Q58029335 | ||
| Detection of Restriction Enzyme Digested Target DNA by PCR Amplification Using a Stem-Loop Primer: Application to the Detection of Hypomethylated Fetal DNA in Maternal Plasma | Q58029371 | ||
| Noninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical Considerations | Q58029492 | ||
| Prenatal exclusion of β thalassaemia major by examination of maternal plasma | Q58029823 | ||
| Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term | Q58029876 | ||
| A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes | Q68019576 | ||
| Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21 | Q73045748 | ||
| Prenatal DNA diagnosis of a single-gene disorder from maternal plasma | Q73074402 | ||
| Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses | Q73093957 | ||
| Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma | Q73141494 | ||
| From genomics to epigenomics: a loftier view of life | Q73238215 | ||
| Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma | Q73406198 | ||
| New strategy for prenatal diagnosis of X-linked disorders | Q74053620 | ||
| A tiling resolution DNA microarray with complete coverage of the human genome | Q76380637 | ||
| Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma | Q77372981 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 30-35 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Chimerism | Q26842138 |
| P1476 | title | Epigenetic approaches for the detection of fetal DNA in maternal plasma | |
| P478 | volume | 1 |
| Q53060571 | Assessment of free fetal DNA concentration in maternal plasma during the first trimester of pregnancy: comparative study between EDTA and PPT tubes - pilot study. |
| Q35738581 | Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing |
| Q38371846 | Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation |
| Q98735793 | Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine |
| Q36846222 | Comparison of different blood sample processing methods for sensitive detection of low level chimerism by RHD real-time PCR assay |
| Q35020525 | Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease |
| Q34059853 | Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors |
| Q34130280 | Marked methylation changes in intestinal genes during the perinatal period of preterm neonates |
| Q33832718 | Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma |
| Q82261782 | Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma |
| Q33891689 | The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis |
Search more.